C C Zielinski

818 total citations
25 papers, 570 citations indexed

About

C C Zielinski is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Molecular Biology. According to data from OpenAlex, C C Zielinski has authored 25 papers receiving a total of 570 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Pulmonary and Respiratory Medicine, 8 papers in Oncology and 5 papers in Molecular Biology. Recurrent topics in C C Zielinski's work include Renal cell carcinoma treatment (3 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (3 papers). C C Zielinski is often cited by papers focused on Renal cell carcinoma treatment (3 papers), Immune Cell Function and Interaction (3 papers) and Immunotherapy and Immune Responses (3 papers). C C Zielinski collaborates with scholars based in Austria, United States and Germany. C C Zielinski's co-authors include Markus Raderer, C Wiltschke, T. Brodowicz, Michael Hejna, Andreas Chott, G. Steger, Wolfgang J. Köstler, Johannes Drach, Ulrich Jäger and Manuela Schmidinger and has published in prestigious journals such as Journal of Clinical Oncology, British Journal of Cancer and Annals of Oncology.

In The Last Decade

C C Zielinski

23 papers receiving 540 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
C C Zielinski Austria 13 266 201 140 137 80 25 570
Phillip Barnette United States 11 255 1.0× 146 0.7× 189 1.4× 123 0.9× 47 0.6× 26 672
J. Yau United States 13 275 1.0× 82 0.4× 270 1.9× 152 1.1× 41 0.5× 19 700
J Chauvergne France 16 353 1.3× 208 1.0× 121 0.9× 228 1.7× 35 0.4× 107 833
T. Megha Italy 9 216 0.8× 67 0.3× 157 1.1× 190 1.4× 76 0.9× 15 504
Ewa Chmielowska Poland 12 251 0.9× 132 0.7× 109 0.8× 119 0.9× 46 0.6× 44 468
Katherine Seibert United States 8 138 0.5× 69 0.3× 105 0.8× 86 0.6× 30 0.4× 10 392
E. Heidemann Germany 12 509 1.9× 155 0.8× 92 0.7× 433 3.2× 58 0.7× 42 793
D. P. Ryan United States 13 241 0.9× 180 0.9× 94 0.7× 39 0.3× 40 0.5× 31 510
JoAnn C. Kelly United States 11 192 0.7× 105 0.5× 76 0.5× 102 0.7× 15 0.2× 17 466
Ritsuto Fujiwaki Japan 17 215 0.8× 87 0.4× 357 2.5× 46 0.3× 90 1.1× 55 834

Countries citing papers authored by C C Zielinski

Since Specialization
Citations

This map shows the geographic impact of C C Zielinski's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C C Zielinski with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C C Zielinski more than expected).

Fields of papers citing papers by C C Zielinski

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C C Zielinski. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C C Zielinski. The network helps show where C C Zielinski may publish in the future.

Co-authorship network of co-authors of C C Zielinski

This figure shows the co-authorship network connecting the top 25 collaborators of C C Zielinski. A scholar is included among the top collaborators of C C Zielinski based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C C Zielinski. C C Zielinski is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zielinski, C C, et al.. (2015). Long-Term Follow-Up of Patients with Graves� Orbitopathy Treated by Plasmapheresis and Immunosuppression. Developments in ophthalmology. 20. 130–138. 1 indexed citations
2.
Lamm, Wolfgang, Wolfgang Willenbacher, Alois Lang, et al.. (2010). Efficacy of the combination of bortezomib and dexamethasone in systemic AL amyloidosis. Annals of Hematology. 90(2). 201–206. 47 indexed citations
3.
Schmidinger, Manuela, Ursula Vogl, Wolfgang Lamm, et al.. (2008). Temsirolimus in heavily pretreated patients with metastatic renal cell carcinoma: Preliminary results from the Austrian Compassionate Use Program. Journal of Clinical Oncology. 26(15_suppl). 16125–16125. 9 indexed citations
4.
Schmidinger, Manuela, Ursula Vogl, Christoph Schukro, et al.. (2007). Cardiac involvement in patients with sorafenib or sunitinib treatment for metastatic renal cell carcinoma. Journal of Clinical Oncology. 25(18_suppl). 5110–5110. 4 indexed citations
5.
Grünberger, Birgit, W. Hauff, Julius Lukas, et al.. (2006). ‘Blind’ antibiotic treatment targeting Chlamydia is not effective in patients with MALT lymphoma of the ocular adnexa. Annals of Oncology. 17(3). 484–487. 49 indexed citations
6.
Bilban, Martin, Daniel Heintel, Theresa Scharl, et al.. (2006). Deregulated expression of fat and muscle genes in B-cell chronic lymphocytic leukemia with high lipoprotein lipase expression. Leukemia. 20(6). 1080–1088. 56 indexed citations
7.
Gnant, Michael, Irene Kuehrer, B. Teleky, et al.. (2004). Effect of neoadjuvant chemotherapy with gemcitabine and docetaxel on 3-year survival and resection rate in previously unresectable locally advanced pancreatic cancer. Journal of Clinical Oncology. 22(14_suppl). 4234–4234. 1 indexed citations
8.
Hejna, Michael, Markus Raderer, & C C Zielinski. (2002). Multimodality Treatment of Gastric Cancer. European surgery. Supplement/European surgery. 34(1). 29–31.
9.
Raderer, Markus, Andreas Chott, Johannes Drach, et al.. (2002). Chemotherapy for management of localised high-grade gastric B-cell lymphoma: how much is necessary?. Annals of Oncology. 13(7). 1094–1098. 46 indexed citations
10.
Wenzel, Catharina, Gottfried J. Locker, Manuela Schmidinger, et al.. (2002). Capecitabine in the treatment of metastatic renal cell carcinoma failing immunotherapy. American Journal of Kidney Diseases. 39(1). 48–54. 23 indexed citations
11.
Hejna, Michael, Wolfgang J. Köstler, Markus Raderer, et al.. (2001). Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF. European Journal of Cancer. 37(16). 1994–2002. 51 indexed citations
12.
Schmidinger, Manuela, Alexandra C. Budinsky, Maria Piribauer, et al.. (2000). Glutathione in the prevention of cisplatin induced toxicities. A prospectively randomized pilot trial in patients with head and neck cancer and non small cell lung cancer.. PubMed. 112(14). 617–23. 34 indexed citations
13.
Brodowicz, T., Eva Schwameis, Joachim Widder, et al.. (2000). Intensified Adjuvant IFADIC Chemotherapy for Adult Soft Tissue Sarcoma: A Prospective Randomized Feasibility Trial. Sarcoma. 4(4). 151–160. 78 indexed citations
14.
Wagner, Theresa, Regine Ahner, Alexandra Auterith, et al.. (2000). Attitude towards prophylactic surgery and effects of genetic counselling in families with BRCA mutations. British Journal of Cancer. 82(7). 1249–1253. 67 indexed citations
15.
Köstler, Wolfgang J., Thomas Brodowicz, Michael Hejna, C Wiltschke, & C C Zielinski. (2000). Detection of minimal residual disease in patients with cancer: a review of techniques, clinical implications, and emerging therapeutic consequences.. PubMed. 24(4). 376–403. 18 indexed citations
16.
Locker, Gottfried J., Julia Kofler, Brigitte Stoiser, et al.. (2000). Relation of pro- and anti-inflammatory cytokines and the production of nitric oxide in patients receiving high-dose immunotherapy with interleukin-2.. PubMed. 11(3). 391–6. 6 indexed citations
17.
Wiltschke, C, Michael Krainer, Andreas Wagner, Werner Linkesch, & C C Zielinski. (1995). Influence of in vivo administration of GM-CSF and G-CSF on monocyte cytotoxicity.. PubMed. 23(5). 402–6. 25 indexed citations
18.
Weissel, M, et al.. (1993). [Combined therapy with cyclosporin A and cortisone in endocrine Basedow endocrine orbitopathy: successful use in compressive optic neuropathy].. PubMed. 20(1-2). 9–13. 4 indexed citations
19.
Müller, Ch., C C Zielinski, Hermann M. Wolf, et al.. (1989). Effects of cyclosporin A upon humoral and cellular immune parameters in insulin-dependent diabetes mellitus type I: a long-term follow-up study. Journal of Endocrinology. 121(1). 177–183. 11 indexed citations
20.
Eibl, M, et al.. (1980). Con A-induced suppressor cells in children with acute lymphoblastic leukaemia.. PubMed. 40(3). 586–92. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026